This meeting took place in 2016
Here are the related meetings in 2018:
Advances in Neurodegenerative Disease Research and Therapy (Z3)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Common Mechanisms of Neurodegeneration (Z3)
Organizer(s) Bradley T. Hyman, Adriano M. Aguzzi and Ricardo E. Dolmetsch
June 12—16, 2016
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Feb 11, 2016
Abstract Deadline: Mar 10, 2016
Scholarship Deadline: Feb 11, 2016
Discounted Registration Deadline: Apr 12, 2016
Sponsored by BioLegend, Inc., Curemark LLC, FORUM Pharmaceuticals Inc., Merck & Co., Inc., Sangamo BioSciences, Inc. and Takeda Pharmaceutical Company Limited
Joint Meeting:
Microglia in the Brain (Z4)
Summary of Meeting:
Recent advances in understanding the genetics and underlying mechanisms of neurodegenerative diseases including prion diseases, Alzheimer’s, Parkinson’s, ALS and frontotemporal dementia have revealed overlaps of phenotypes, genetic risks and biological mechanisms across this spectrum of disorders. The “common mechanisms” include protein templating, glial and inflammatory mechanisms, new understanding of RNA-based toxicity and of toxicity associated with protein misfolding, and common downstream mechanisms affecting synaptic function. Moreover, because there appear to be common mechanisms at play, recent progress in therapeutic approaches targeting one of these disorders may have applicability across the whole range of disorders. This Keystone Symposia conference will enable the in-depth exploration of these various aspects of commonality across neurodegenerative disorders.
View Meeting Program
Recent advances in understanding the genetics and underlying mechanisms of neurodegenerative diseases including prion diseases, Alzheimer’s, Parkinson’s, ALS and frontotemporal dementia have revealed overlaps of phenotypes, genetic risks and biological mechanisms across this spectrum of disorders. The “common mechanisms” include protein templating, glial and inflammatory mechanisms, new understanding of RNA-based toxicity and of toxicity associated with protein misfolding, and common downstream mechanisms affecting synaptic function. Moreover, because there appear to be common mechanisms at play, recent progress in therapeutic approaches targeting one of these disorders may have applicability across the whole range of disorders. This Keystone Symposia conference will enable the in-depth exploration of these various aspects of commonality across neurodegenerative disorders.
View Meeting Program
Scholarships/Awards
Burroughs Wellcome Fund ECITA Scholarship Recipients
Diana Laura Castillo-CarranzaHampton University, USA
National Institute of Neurological Disorders and Stroke (NINDS) Scholarship Recipients
Christoph GerickeUniversity of Zurich, Switzerland
Jing Guo
University of Pennsylvania, USA
Soyon Hong
Boston Children's Hospital, USA
Eleanna Kara
Massachusetts General Hospital, USA
Esteban Luna
University of Pennsylvania, USA
William A. McEwan
MRC Laboratory of Molecular Biology, UK
Mai Nakamura
Johns Hopkins Medical Institutions, USA
Joshua Wheeler
University of Colorado Boulder, USA
The Elkes Foundation Scholarship Recipients
Flora HinzUniversity of California, Los Angeles, USA
